Stanford Jhee

Stan is a clinical pharmacologist with expertise in a wide range of early drug development studies from first-in-human through proof of concept. His work involves drugs in a variety of therapeutic areas, including infectious diseases. He works closely as an expert partner with his pharmaceutical industry colleagues in the strategic planning, protocol development, clinical conduct, data analysis, and reporting of clinical studies. He also serves as an expert on ethnic sensitivity studies (ethnobridging) to help pharmaceutical companies gather Asian data in the U.S. and UK in support of Asian drug development.

Work Experience
Stan’s clinical research career began as a research fellow at USC/Los Angeles County General Hospital, where his area of research was in application of population pharmacokinetics in studying ethnic factors in antibiotics drug disposition. Following his fellowship, he joined California Clinical Trials (now part of Parexel) in 1993 as a clinical pharmacologist. 

In 2000, he pioneered the concept of collecting Japanese data in Los Angeles to help pharmaceutical companies gain entry into Asian development, coining the term ethnobridging. Under his leadership, Parexel has now conducted more than 300 Asian studies, expanding the service to include Chinese and Korean subjects in addition to the Japanese.

Stan has authored over 95 peer-reviewed scholarly articles and has written three books on ethnobridging as the lead author. He is a member of the American Society of Clinical Pharmacology as well as the Japanese Society of Clinical Pharmacology. 

Education
Stan studied biological sciences at the University of California at Irvine and received his Doctor of Pharmacy degree from the University of Southern California (USC). He further pursued his post-doctorate fellowship in infectious diseases at USC.